(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DRUG DISCOVERY AI FACTORY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DRUG DISCOVERY AI FACTORY

ST13

US500000079393432

Class

9, 35, 41, 42

Filing

79393432

Registration

7665758

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

04/03/2026

Trademark type

Word

Nice classes

9, 35, 41, 42

Filing date

12/13/2023

Registration date

01/28/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/28/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

PARKS, KIMBERLY L

Law office

M30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

FRONTEO, Inc.

Representatives

Tomoko Nakajima Future IP LLC

Technical classification

Nice Classes

Class 9Class 35Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; downloadable computer programs for proposing and searching indications; downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; devices for analyzing electronic images; downloadable computer programs for data processing; devices for data processing; computer hardware for data processing

Class 35

Compilation of information into computer databases for research in the field of pharmaceuticals

Class 41

Providing information on educational and instruction services relating to medicine and pharmaceuticals; arranging and conducting seminars relating to medicine and pharmaceuticals; instruction services in the field of pharmaceuticals

Class 42

Providing on-line non-downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for proposing and searching indications; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; provision of information search engines via internet; designing and creating services of home pages and websites; designingprogrammingmaintenance of computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; designingprogrammingmaintenance of computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; designingprogrammingmaintenance of computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; designingprogrammingmaintenance of computer programs for proposing and searching indications; designingprogrammingmaintenance of computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; scientific testinginspection and research for making a hypothesis on relationships between genes and diseases; testinginspection or research of pharmaceuticals; consulting services relating to testinginspection and research of pharmaceuticals; providing information on research of pharmaceuticals; drug discovery services; research and scientific inspection of pharmaceuticals relating to genetic analysis; scientific testing and research on health equipment; rental of measuring and testing instruments; rental of measuring apparatus; hosting web portals on the Internet; rental of server memory space for social networking websites; rental of computers

Publications

History of USPTO decisions and trademark events.

28 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/11/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/26/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

11/26/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/05/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/15/2025

FIMP

FINAL DISPOSITION PROCESSED

08/15/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/29/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/28/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/10/2024

PUBO

PUBLISHED FOR OPPOSITION

12/10/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/04/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/14/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/04/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/04/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/04/2024

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

09/18/2024

RFNT

REFUSAL PROCESSED BY IB

08/25/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/07/2024

RFRR

REFUSAL PROCESSED BY MPU

08/07/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/21/2024

CNRT

NON-FINAL ACTION WRITTEN

07/20/2024

DOCK

ASSIGNED TO EXAMINER

07/11/2024

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

06/30/2024

MAFR

APPLICATION FILING RECEIPT MAILED

04/23/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/18/2024

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

04/16/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/11/2024

Continuous trademark protection

Get notified about every new filing that threatens DRUG DISCOVERY AI FACTORY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.